rdf:type |
|
lifeskim:mentions |
umls-concept:C0001554,
umls-concept:C0022341,
umls-concept:C0024299,
umls-concept:C0027651,
umls-concept:C0038951,
umls-concept:C0392752,
umls-concept:C1257890,
umls-concept:C1273870,
umls-concept:C1332225,
umls-concept:C1337615,
umls-concept:C1514474,
umls-concept:C1522449
|
pubmed:issue |
1
|
pubmed:dateCreated |
2000-8-17
|
pubmed:abstractText |
To identify the prognostic factors that specifically predict survival rates of patients with localized aggressive non-Hodgkin's lymphoma (NHL).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0360-3016
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
48
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
161-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10924986-Adult,
pubmed-meshheading:10924986-Aged,
pubmed-meshheading:10924986-Aged, 80 and over,
pubmed-meshheading:10924986-Analysis of Variance,
pubmed-meshheading:10924986-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:10924986-Bleomycin,
pubmed-meshheading:10924986-Combined Modality Therapy,
pubmed-meshheading:10924986-Cyclophosphamide,
pubmed-meshheading:10924986-Doxorubicin,
pubmed-meshheading:10924986-Female,
pubmed-meshheading:10924986-Humans,
pubmed-meshheading:10924986-Japan,
pubmed-meshheading:10924986-Leucovorin,
pubmed-meshheading:10924986-Lymphoma, Non-Hodgkin,
pubmed-meshheading:10924986-Male,
pubmed-meshheading:10924986-Methotrexate,
pubmed-meshheading:10924986-Middle Aged,
pubmed-meshheading:10924986-Neoplasm Staging,
pubmed-meshheading:10924986-Prednisone,
pubmed-meshheading:10924986-Prognosis,
pubmed-meshheading:10924986-Proportional Hazards Models,
pubmed-meshheading:10924986-Radiation Injuries,
pubmed-meshheading:10924986-Radiotherapy Dosage,
pubmed-meshheading:10924986-Survival Rate,
pubmed-meshheading:10924986-Vincristine
|
pubmed:year |
2000
|
pubmed:articleTitle |
Tumor bulk as a prognostic factor for the management of localized aggressive non-Hodgkin's lymphoma: a survey of the Japan Lymphoma Radiation Therapy Group.
|
pubmed:affiliation |
Department of Radiology, Shinshu University, School of Medicine, Matsumoto, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|